676 related articles for article (PubMed ID: 31648943)
1. Tricarboxylic acid cycle enzyme activities in a mouse model of methylmalonic aciduria.
Wongkittichote P; Cunningham G; Summar ML; Pumbo E; Forny P; Baumgartner MR; Chapman KA
Mol Genet Metab; 2019 Dec; 128(4):444-451. PubMed ID: 31648943
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and anaplerotic applications of in vitro models of propionic acidemia and methylmalonic acidemia using patient-derived primary hepatocytes.
Collado MS; Armstrong AJ; Olson M; Hoang SA; Day N; Summar M; Chapman KA; Reardon J; Figler RA; Wamhoff BR
Mol Genet Metab; 2020 Jul; 130(3):183-196. PubMed ID: 32451238
[TBL] [Abstract][Full Text] [Related]
3. In-depth phenotyping reveals common and novel disease symptoms in a hemizygous knock-in mouse model (Mut-ko/ki) of mut-type methylmalonic aciduria.
Lucienne M; Aguilar-Pimentel JA; Amarie OV; Becker L; Calzada-Wack J; da Silva-Buttkus P; Garrett L; Hölter SM; Mayer-Kuckuk P; Rathkolb B; Rozman J; Spielmann N; Treise I; Busch DH; Klopstock T; Schmidt-Weber C; Wolf E; Wurst W; Forny M; Mathis D; Fingerhut R; Froese DS; Gailus-Durner V; Fuchs H; de Angelis MH; Baumgartner MR
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165622. PubMed ID: 31770620
[TBL] [Abstract][Full Text] [Related]
4. Novel Mouse Models of Methylmalonic Aciduria Recapitulate Phenotypic Traits with a Genetic Dosage Effect.
Forny P; Schumann A; Mustedanagic M; Mathis D; Wulf MA; Nägele N; Langhans CD; Zhakupova A; Heeren J; Scheja L; Fingerhut R; Peters HL; Hornemann T; Thony B; Kölker S; Burda P; Froese DS; Devuyst O; Baumgartner MR
J Biol Chem; 2016 Sep; 291(39):20563-73. PubMed ID: 27519416
[TBL] [Abstract][Full Text] [Related]
5. Integrated multi-omics reveals anaplerotic rewiring in methylmalonyl-CoA mutase deficiency.
Forny P; Bonilla X; Lamparter D; Shao W; Plessl T; Frei C; Bingisser A; Goetze S; van Drogen A; Harshman K; Pedrioli PGA; Howald C; Poms M; Traversi F; Bürer C; Cherkaoui S; Morscher RJ; Simmons L; Forny M; Xenarios I; Aebersold R; Zamboni N; Rätsch G; Dermitzakis ET; Wollscheid B; Baumgartner MR; Froese DS
Nat Metab; 2023 Jan; 5(1):80-95. PubMed ID: 36717752
[TBL] [Abstract][Full Text] [Related]
6. FGF21 underlies a hormetic response to metabolic stress in methylmalonic acidemia.
Manoli I; Sysol JR; Epping MW; Li L; Wang C; Sloan JL; Pass A; Gagné J; Ktena YP; Li L; Trivedi NS; Ouattara B; Zerfas PM; Hoffmann V; Abu-Asab M; Tsokos MG; Kleiner DE; Garone C; Cusmano-Ozog K; Enns GM; Vernon HJ; Andersson HC; Grunewald S; Elkahloun AG; Girard CL; Schnermann J; DiMauro S; Andres-Mateos E; Vandenberghe LH; Chandler RJ; Venditti CP
JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518688
[TBL] [Abstract][Full Text] [Related]
7. Development of transgenic mice containing an introduced stop codon on the human methylmalonyl-CoA mutase locus.
Buck NE; Dashnow H; Pitt JJ; Wood LR; Peters HL
PLoS One; 2012; 7(9):e44974. PubMed ID: 23024777
[TBL] [Abstract][Full Text] [Related]
8. Targeting proximal tubule mitochondrial dysfunction attenuates the renal disease of methylmalonic acidemia.
Manoli I; Sysol JR; Li L; Houillier P; Garone C; Wang C; Zerfas PM; Cusmano-Ozog K; Young S; Trivedi NS; Cheng J; Sloan JL; Chandler RJ; Abu-Asab M; Tsokos M; Elkahloun AG; Rosen S; Enns GM; Berry GT; Hoffmann V; DiMauro S; Schnermann J; Venditti CP
Proc Natl Acad Sci U S A; 2013 Aug; 110(33):13552-7. PubMed ID: 23898205
[TBL] [Abstract][Full Text] [Related]
9. Systematic literature review and meta-analysis on the epidemiology of methylmalonic acidemia (MMA) with a focus on MMA caused by methylmalonyl-CoA mutase (mut) deficiency.
Almási T; Guey LT; Lukacs C; Csetneki K; Vokó Z; Zelei T
Orphanet J Rare Dis; 2019 Apr; 14(1):84. PubMed ID: 31023387
[TBL] [Abstract][Full Text] [Related]
10. Adenoviral-mediated correction of methylmalonyl-CoA mutase deficiency in murine fibroblasts and human hepatocytes.
Chandler RJ; Tsai MS; Dorko K; Sloan J; Korson M; Freeman R; Strom S; Venditti CP
BMC Med Genet; 2007 Apr; 8():24. PubMed ID: 17470278
[TBL] [Abstract][Full Text] [Related]
11. The existence of a nonclassical TCA cycle in the nucleus that wires the metabolic-epigenetic circuitry.
Liu X; Si W; He L; Yang J; Peng Y; Ren J; Liu X; Jin T; Yu H; Zhang Z; Cheng X; Zhang W; Xia L; Huang Y; Wang Y; Liu S; Shan L; Zhang Y; Yang X; Li H; Liang J; Sun L; Shang Y
Signal Transduct Target Ther; 2021 Nov; 6(1):375. PubMed ID: 34728602
[TBL] [Abstract][Full Text] [Related]
12. Treatment of a methylmalonyl-CoA mutase stopcodon mutation.
Buck NE; Wood LR; Hamilton NJ; Bennett MJ; Peters HL
Biochem Biophys Res Commun; 2012 Nov; 427(4):753-7. PubMed ID: 23041189
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers to predict disease progression and therapeutic response in isolated methylmalonic acidemia.
Manoli I; Gebremariam A; McCoy S; Pass AR; Gagné J; Hall C; Ferry S; Van Ryzin C; Sloan JL; Sacchetti E; Catesini G; Rizzo C; Martinelli D; Spada M; Dionisi-Vici C; Venditti CP
J Inherit Metab Dis; 2023 Jul; 46(4):554-572. PubMed ID: 37243446
[TBL] [Abstract][Full Text] [Related]
14. A novel small molecule approach for the treatment of propionic and methylmalonic acidemias.
Armstrong AJ; Collado MS; Henke BR; Olson MW; Hoang SA; Hamilton CA; Pourtaheri TD; Chapman KA; Summar MM; Johns BA; Wamhoff BR; Reardon JE; Figler RA
Mol Genet Metab; 2021 May; 133(1):71-82. PubMed ID: 33741272
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction in mut methylmalonic acidemia.
Chandler RJ; Zerfas PM; Shanske S; Sloan J; Hoffmann V; DiMauro S; Venditti CP
FASEB J; 2009 Apr; 23(4):1252-61. PubMed ID: 19088183
[TBL] [Abstract][Full Text] [Related]
16. Molecular Genetic Characterization of 151 Mut-Type Methylmalonic Aciduria Patients and Identification of 41 Novel Mutations in MUT.
Forny P; Schnellmann AS; Buerer C; Lutz S; Fowler B; Froese DS; Baumgartner MR
Hum Mutat; 2016 Aug; 37(8):745-54. PubMed ID: 27167370
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Novel Mutations and Methylmalonyl-CoA Mutase Levels in Thai Patients with Isolated Methylmalonic Acidemia.
Sawangareetrakul P; Ketudat Cairns JR; Vatanavicharn N; Liammongkolkul S; Wasant P; Svasti J; Champattanachai V
Biochem Genet; 2015 Dec; 53(11-12):310-8. PubMed ID: 26370686
[TBL] [Abstract][Full Text] [Related]
18. Systemic Messenger RNA Therapy as a Treatment for Methylmalonic Acidemia.
An D; Schneller JL; Frassetto A; Liang S; Zhu X; Park JS; Theisen M; Hong SJ; Zhou J; Rajendran R; Levy B; Howell R; Besin G; Presnyak V; Sabnis S; Murphy-Benenato KE; Kumarasinghe ES; Salerno T; Mihai C; Lukacs CM; Chandler RJ; Guey LT; Venditti CP; Martini PGV
Cell Rep; 2017 Dec; 21(12):3548-3558. PubMed ID: 29262333
[TBL] [Abstract][Full Text] [Related]
19. Pyruvate Dehydrogenase and Tricarboxylic Acid Cycle Enzymes Are Sensitive Targets of Traumatic Brain Injury Induced Metabolic Derangement.
Lazzarino G; Amorini AM; Signoretti S; Musumeci G; Lazzarino G; Caruso G; Pastore FS; Di Pietro V; Tavazzi B; Belli A
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744143
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
